Abstract
The effect of subthalamic deep brain stimulation (STN DBS) on cognition in Parkinson’s disease (PD) remains controversial, and it is unclear which factors are related to cognitive decline and dementia after STN DBS, especially over the long term. To this end, we analyzed the cognitive outcome of 103 non-demented patients with PD who were followed-up for at least 12 months after bilateral STN DBS surgery. Preoperatively, the patients were evaluated with the Unified Parkinson's Disease Rating Scale and neuropsychological tests. The rate of global cognitive decline and the incidence of dementia during follow-up for up to 7 years (mean 42.4 ± 24.5 months) were calculated, and preoperative clinical and neuropsychological factors associated with postoperative global cognitive decline or dementia were analyzed. The prevalence of mild cognitive impairment (MCI) and its relation to later cognitive decline or dementia were also evaluated. The annual decline in the mini–mental state examination score was 0.4 ± 1.7 with impaired attention and executive function and a higher levodopa equivalent dose at baseline being the predictors of a faster global cognitive decline after STN DBS. Dementia developed in 13 patients with an incidence rate of 35.7 per 1,000 person-years. Impaired executive function at baseline predicted dementia. At baseline, 63.1 % of the patients had PD-MCI, and these patients were more likely to develop dementia than those without PD-MCI. This study showed that dysfunctions in the frontostriatal circuitry at baseline were associated with a risk of subsequent global cognitive decline and dementia in patients with PD who underwent STN DBS. In addition, preoperative PD-MCI was a risk factor for dementia after STN DBS.
Similar content being viewed by others
References
Castrioto A, Lhommée E, Moro E, Krack P (2014) Mood and behavioural effects of subthalamic stimulation in Parkinson’s disease. Lancet Neurol 13:287–305
Massano J, Garrett C (2012) Deep brain stimulation and cognitive decline in Parkinson’s disease: a clinical review. Front Neurol 3:66. doi:10.3389/fneur.2012.00066
Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A (2010) Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain 133:2664–2676
Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, Artusi CA, Lanotte M, Rizzone MG, Lopiano L (2011) Parkinson’s disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 134:2074–2084
Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A (2008) Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 7:605–614
Zangaglia R, Pasotti C, Mancini F, Servello D, Sinforiani E, Pacchetti C (2012) Deep brain stimulation and cognition in Parkinson’s disease: an eight-year follow-up study. Mov Disord 27:1192–1194
Castrioto A, Lozano AM, Poon Y-Y, Lang AE, Fallis M, Moro E (2011) Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 68:1550–1556
Zibetti M, Merola A, Rizzi L, Ricchi V, Angrisano S, Azzaro C, Artusi CA, Arduino N, Marchisio A, Lanotte M (2011) Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Mov Disord 26:2327–2334
Hoops S, Nazem S, Siderowf A, Duda J, Xie S, Stern M, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73:1738–1745
Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245
Pai MC, Chan SH (2001) Education and cognitive decline in Parkinson’s disease: a study of 102 patients. Acta Neurol Scand 103:243–247
Siderowf A, Xie S, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw L, Van Deerlin V, Trojanowski J, Clark C (2010) CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease. Neurology 75:1055–1061
Williams-Gray C, Foltynie T, Brayne C, Robbins T, Barker R (2007) Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain 130:1787–1798
Kim HJ, Jeon BS, Paek SH, Lee JY, Kim HJ, Kim CK, Kim DG (2010) Bilateral subthalamic deep brain stimulation in Parkinson disease patients with severe tremor. Neurosurgery 67:626–632
Kim HJ, Paek SH, Kim JY, Lee JY, Lim YH, Kim DG, Jeon BS (2009) Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson’s disease. Mov Disord 24:329–335. doi:10.1002/mds.22211
Lee JY, Han JH, Kim HJ, Jeon BS, Kim DG, Paek SH (2008) STN DBS of advanced Parkinson’s disease experienced in a specialized monitoring unit with a prospective protocol. J Korean Neurosurg Soc 44:26–35. doi:10.3340/jkns.2008.44.1.26
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Heo JH, Lee KM, Paek SH, Kim MJ, Lee JY, Kim JY, Cho SY, Lim YH, Kim MR, Jeong SY (2008) The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. J Neurol Sci 273:19–24
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349–356
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707
Aybek S, Gronchi-Perrin A, Berney A, Chiuvé SC, Villemure JG, Burkhard PR, Vingerhoets FJG (2007) Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson’s disease. Mov Disord 22:974–981
Smeding HMM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B (2011) Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s disease. J Neurol Neurosurg Psychiatry 82:754–760
Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET. Brain 125:584–594
Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ (2009) The distinct cognitive syndromes of Parkinson’s disease: 5-year follow-up of the CamPaIGN cohort. Brain 132:2958–2969
Castelli L, Rizzi L, Zibetti M, Angrisano S, Lanotte M, Lopiano L (2010) Neuropsychological changes 1 year after subthalamic DBS in PD patients: a prospective controlled study. Parkinsonism Relat Disord 16:115–118
Daniels C, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A, Wojtecki L, Bötzel K (2010) Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson’s disease. Mov Disord 25:1583–1589
Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK (2011) Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord 17:321–327
de Lau LM, Schipper CMA, Hofman A, Koudstaal PJ, Breteler M (2005) Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 62:1265–1269
Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64:S81–S92
Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062–1069
Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D (2011) MDS task force on mild cognitive impairment in Parkinson’s disease: critical review of PD-MCI. Mov Disord 26:1814–1824
Janvin C, Larsen J, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 21:1343–1349
Pedersen KF, Larsen JP, Tysnes O-B, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian Park West Study. JAMA Neurol 70:580–586
Lessig S, Nie D, Xu R, Corey-Bloom J (2012) Changes on brief cognitive instruments over time in Parkinson’s disease. Mov Disord 27:1125–1128
Aarsland D, Muniz G, Matthews F (2011) Nonlinear decline of mini-mental state examination in Parkinson’s disease. Mov Disord 26:334–337
Acknowledgments
This study was supported by grants from the Korea Health technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A101273), the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea. (HI12C0205), and the Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea (311011-05-1-SB010).
Conflicts of interest
Dr. H. J. Kim reports no disclosures. Dr. B. S. Jeon has received funding for travel from Medtronics. Dr. S. H. Paek, Dr. K. M. Lee, Dr. J. Y. Kim, Dr. J. Y. Lee, Dr. H. J. Kim, Dr. J. Y. Yun, Dr. Y. E. Kim, Dr. H. J. Yang and Dr. G. Ehm reports no disclosures.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kim, HJ., Jeon, B.S., Paek, S.H. et al. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease. J Neurol 261, 1090–1096 (2014). https://doi.org/10.1007/s00415-014-7321-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-014-7321-z